STERIS plc (STE)
NYSE · Healthcare
STERIS plc EBITDA 2017–2026
STERIS plc annual/quarterly ebitda history and growth rate from 2017 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- STERIS plc ebitda for the quarter ending June 30, 2025 was 365.4 M, a 22.54% increase year-over-year.
- STERIS plc ebitda for the twelve months ending June 30, 2025 was 1.3 B, a 131.04% increase year-over-year.
- STERIS plc annual ebitda for 2026 was 1.6 B, a 18.28% increase from 2025.
- STERIS plc annual ebitda for 2025 was 1.3 B, a 4.17% decrease from 2024.
- STERIS plc annual ebitda for 2024 was 1.4 B, a 4.26% increase from 2023.
- STERIS plc annual ebitda for 2023 was 1.3 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
STERIS plc EBITDA — FAQ
STERIS plc (STE) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STE's ebitda history?
The chart and table above show STERIS plc's ebitda by year and by quarter, including the growth rate.